UB receives A 1.78 million to find new therapies for treating heart failure and diabetes


The University of Birmingham has been awarded 1.78 million by the Wellcome Trust for research aimed at finding new therapies to treat diseases such as heart failure, diabetes and neurodegenerative disorders. The Wellcome Trust Senior Research Fellowship funding has been awarded to Davide Calebiro, Professor of Molecular Endocrinology at the University of Birmingham's Institute of Metabolism and Systems Research and principal investigator at the Centre of Membrane Proteins and Receptors at the Universities of Birmingham and Nottingham.



from Biotech News